Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients
oleh: Mathilde Lamarque, Céline Bossard, Adrien Contejean, Pauline Brice, Marie Parrens, Steven Le Gouill, Josette Brière, Reda Bouabdallah, Danielle Canioni, Hervé Tilly, Brigitte Bouchindhomme, Emmanuel Bachy, Richard Delarue, Corinne Haioun, Philippe Gaulard
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2016-03-01 |
Deskripsi
No description available for this item.